Stock Ticker

  • Loading stock data...

DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity

Dyadic International Inc (NASDAQ:DYAI) is in an interesting position, being one of the very few names in the anti-Covid space that offer a new path that isn’t simply a reproduction or tie-in to the big pharma game right now. DYAI has a new approach that isn’t new-age quote-unquote “science”, but a powerful new potential solution […]

Interest Picking Up in Medical REITs Such as Supurva Healthcare Group Inc (OTCMKTS:SPRV)

Healthcare real estate investment trusts (REITs) have a well-earned reputation as stable relatively invincible investable assets. However, due to the pandemic and its many collateral consequences, the long-term outlook for the space has become more interesting, with a decentralization theme beginning to gain increasing traction. The ultimate driver is demographics and cost structures. But the […]

Supurva Healthcare Group Inc (OTCMKTS:SPRV) is a Prime Mover in the Decentralized Healthcare Trend

One of the defining trends that will drive a major part of the economy over the next decade is the decentralization of the healthcare system. Home health spending, an excellent measure of this trend, is expected increase at a faster rate through 2027 than all other categories of care, according to a recent analysis from […]

Spotlight: Progressive Care Inc (OTCMKTS:RXMD) Ramps Up Covid-19 Vaccinations (AZN, MRNA, NVAX, PFE, CVS, WBA, RAD)

The vaccine is now a defining part of the world economy, with Evercore analysts predicting the first round of vaccinations (ie, those taking place this year before adjustments to new variants) will add up to about $140 billion in sales in the US. Stocks related to this theme make up a high interest group that […]

How Dyadic International Inc (NASDAQ:DYAI) Fits into the Vaccine 2.0 Gold Rush (BNTX, JNJ, MRNA, PFE)

Death, Taxes, and Covid shots. The future stretching out in front of us has maybe only these three certainties. The virus is actively mutating constantly, and over some period of time, those mutations will produce a variant that falls outside of the efficacy boundary of current major vaccine platforms, which are now defined mostly by […]

Is Dyadic International Inc (NASDAQ:DYAI) the Key to Scaling Up Global Access to a Viable Covid-19 Vaccine? (NVAX, MRNA, PFE, AZN)

While the pandemic feels “almost over” on many levels, experts believe the fundamental driver – a rapidly mutating coronavirus pathogen with uniquely formidable qualities – is likely, and unfortunately, here to stay as an endemic feature of the human microbiome going forward. In other words, Covid-19 is going to be with us for the long […]

Breaking: Stocks Running on Virus Testing News (TMO, ALST, LH)

Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The measures are a response to recent worrying signs of trouble in the EU in terms of vaccine distribution. New variants and unexpected case increases have everyone back on alert. In […]

Investing in Rapidly Growing Autism Therapy Market (BNGO, ISWH, ZYNE)

While it doesn’t get a lot of press, the Autism market is unfortunately a rapidly growing market opportunity. According to recent data from the CDC, roughly 2% of all kids are now diagnosed with Autism Spectrum Disorder (ASD). That number is up from 0.1% just two decades ago. This staggering rise has led to a […]

The Bull Opportunity Ahead in Telehealth Stocks (TDOC, ONEM, ISWH, AMWL)

Few trends are as easily identifiable as the structural opportunity in the telehealth space. We have undergone a transformative experience as a society over the past year, with so many taken-for-granted facets of daily life halted, rearranged, and rebuilt in what ultimately may be a superior form. That has enormously implications for a number of […]

Sandoz Of Novartis AG (NYSE:NVS) Acquires Antibiotics Of GlaxoSmithKline Plc (NYSE:GSK) For $500 Million

Novartis AG (NYSE:NVS)’s Sandoz entered a deal with GlaxoSmithKline Plc (NYSE:GSK) to acquire the established antibiotic brands like Fortum, Zinacef, and Zinnat for $350 million. GlaxoSmithKline will also receive milestone payments of up to $150 million. The deal will be closed by the end of this year. Sandoz decided to purchase antibiotics brands after it […]

Stocks for the Pandemic Long Haul (FLGT, ALST, HOLX)

Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many years to come, with a constant need for PPE, testing, vaccine rejiggering, specialized air filtration solutions, and other ‘coping’ […]

Pfizer (NYSE:PFE) To Continue Supplying COVID-19 Vaccine In Italy Even As Rome Threatens To Sue

Pfizer (NYSE:PFE) has indicated that it will continue supplying its COVID-19 vaccine to Italy as per the European Commission agreement even as the government considers suing the group’s CEO of the Italian unit. Rome is planning to sue the US pharmaceutical company for falling behind in deliveries of the COVID-19 vaccine. Italy considering suing Pfizer […]

Novartis (NYSE:NVS) Enters Agreement For Manufacture Of Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) mRNA Vaccine

Novartis (NYSE:NVS) has entered an initial agreement with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for manufacturing support to boost production of their mRNA COVID-19 vaccine to help address supply shortages. This is an example of an unlikely collaboration between big pharmaceutical companies geared at the fight against the coronavirus pandemic. Novartis signs vaccine manufacturing […]